Cargando…
Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression
BACKGROUND: Rapid evolution of the therapeutic management of prostate cancer, especially in in second-generation androgen inhibitors, has increased the opportunity of transformation from prostate cancer (PCa) to neuroendocrine prostate cancer (NEPC). NEPC still lacks effective diagnostic and therape...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189092/ https://www.ncbi.nlm.nih.gov/pubmed/35633416 http://dx.doi.org/10.1007/s00432-022-04061-7 |